Muscle atrophy in transgenic mice expressing a human TSC1 transgene
dc.contributor.author | Wan, Min | en_US |
dc.contributor.author | Wu, Xiaohui | en_US |
dc.contributor.author | Guan, Kun-Liang | en_US |
dc.contributor.author | Han, Min | en_US |
dc.contributor.author | Zhuang, Yuan | en_US |
dc.contributor.author | Xu, Tian | en_US |
dc.date.accessioned | 2016-01-04T20:52:06Z | |
dc.date.available | 2016-01-04T20:52:06Z | |
dc.date.issued | 2006-10-16 | en_US |
dc.identifier.citation | Wan, Min; Wu, Xiaohui; Guan, Kun-Liang; Han, Min; Zhuang, Yuan; Xu, Tian (2006). "Muscle atrophy in transgenic mice expressing a human TSC1 transgene." FEBS Letters 580(24): 5621-5627. | en_US |
dc.identifier.issn | 0014-5793 | en_US |
dc.identifier.issn | 1873-3468 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/116374 | |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.subject.other | Muscular atrophy | en_US |
dc.subject.other | Mouse | en_US |
dc.subject.other | Tuberous sclerosis 1 | en_US |
dc.subject.other | Transgenesis | en_US |
dc.title | Muscle atrophy in transgenic mice expressing a human TSC1 transgene | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Biological Chemistry | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Life Sciences Institute, Department of Biological Chemistry, and Institute of Gerontology, University of Michigan, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationother | Institutes of Biomedical Sciences, Fudan University, 220 Handan Road, Shanghai 200433, China | en_US |
dc.contributor.affiliationother | Institute of Developmental Biology and Molecular Medicine, Morgan-Tan International Center for Life Sciences, School of Life Sciences, Fudan University, 220 Handan Road, Shanghai 200433, China | en_US |
dc.contributor.affiliationother | Howard Hughes Medical Institute and Department of Genetics, Yale University School of Medicine, New Haven, CT, USA | en_US |
dc.contributor.affiliationother | Department of Immunology, Duke University Medical Center, Durham, NC, USA | en_US |
dc.contributor.affiliationother | Howard Hughes Medical Institute and Department of MCDB, University of Colorado at Boulder, Boulder, CO, USA | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/116374/1/feb2s0014579306010866.pdf | |
dc.identifier.doi | 10.1016/j.febslet.2006.09.008 | en_US |
dc.identifier.source | FEBS Letters | en_US |
dc.identifier.citedreference | X. Gao, Y. Zhang, P. Arrazola, O. Hino, T. Kobayashi, R.S. Yeung, B. Ru, D. Pan, Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling. Nat. Cell Biol., 4,( 2002 ), 699 – 704. | en_US |
dc.identifier.citedreference | S.C. Bodine, Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat. Cell Biol., 3,( 2001 ), 1014 – 1019. | en_US |
dc.identifier.citedreference | X.D. Peng, Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev., 17,( 2003 ), 1352 – 1365. | en_US |
dc.identifier.citedreference | M. Ohanna, Atrophy of S6K1(−/−) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control. Nat. Cell Biol., 7,( 2005 ), 286 – 294. | en_US |
dc.identifier.citedreference | J. Young, S. Povey, The genetic basis of tuberous sclerosis. Mol. Med. Today, 4,( 1998 ), 313 – 319. | en_US |
dc.identifier.citedreference | C.J. Potter, H. Huang, T. Xu, Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size. Cell, 105,( 2001 ), 357 – 368. | en_US |
dc.identifier.citedreference | C.J. Potter, L.G. Pedraza, T. Xu, Akt regulates growth by directly phosphorylating Tsc2. Nat. Cell Biol., 4,( 2002 ), 658 – 665. | en_US |
dc.identifier.citedreference | K. Inoki, Y. Li, T. Zhu, J. Wu, K.L. Guan, TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol., 4,( 2002 ), 648 – 657. | en_US |
dc.identifier.citedreference | B.D. Manning, A.R. Tee, M.N. Logsdon, J. Blenis, L.C. Cantley, Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol. Cell, 10,( 2002 ), 151 – 162. | en_US |
dc.identifier.citedreference | K.S. Au, J.A. Rodriguez, J.L. Finch, K.A. Volcik, E.S. Roach, M.R. Delgado, E. Rodriguez Jr., H. Northrup, Germ-line mutational analysis of the TSC2 gene in 90 tuberous-sclerosis patients. Am. J. Hum. Genet., 62,( 1998 ), 286 – 294. | en_US |
dc.identifier.citedreference | K. Inoki, Y. Li, T. Xu, K.L. Guan, Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev., 17,( 2003 ), 1829 – 1834. | en_US |
dc.identifier.citedreference | A. Garami, Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol. Cell, 11,( 2003 ), 1457 – 1466. | en_US |
dc.identifier.citedreference | Y. Zhang, X. Gao, L.J. Saucedo, B. Ru, B.A. Edgar, D. Pan, Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat. Cell Biol., 5,( 2003 ), 578 – 581. | en_US |
dc.identifier.citedreference | M. van Slegtenhorst, Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum. Mol. Genet., 7,( 1998 ), 1053 – 1057. | en_US |
dc.identifier.citedreference | G. Benvenuto, The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination. Oncogene, 19,( 2000 ), 6306 – 6316. | en_US |
dc.identifier.citedreference | H.C. Dan, Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin. J. Biol. Chem., 277,( 2002 ), 35364 – 35370. | en_US |
dc.identifier.citedreference | L.D. Aicher, J.S. Campbell, R.S. Yeung, Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis. J. Biol. Chem., 276,( 2001 ), 21017 – 21021. | en_US |
dc.identifier.citedreference | K. Inoki, T. Zhu, K.L. Guan, TSC2 mediates cellular energy response to control cell growth and survival. Cell, 115,( 2003 ), 577 – 590. | en_US |
dc.identifier.citedreference | J.E. Johnson, B.J. Wold, S.D. Hauschka, Muscle creatine kinase sequence elements regulating skeletal and cardiac muscle expression in transgenic mice. Mol. Cell Biol., 9,( 1989 ), 3393 – 3399. | en_US |
dc.identifier.citedreference | Q.T. Nguyen, A.S. Parsadanian, W.D. Snider, J.W. Lichtman, Hyperinnervation of neuromuscular junctions caused by GDNF overexpression in muscle. Science, 279,( 1998 ), 1725 – 1729. | en_US |
dc.identifier.citedreference | M.A. Shield, H.S. Haugen, C.H. Clegg, S.D. Hauschka, E-box sites and a proximal regulatory region of the muscle creatine kinase gene differentially regulate expression in diverse skeletal muscles and cardiac muscle of transgenic mice. Mol. Cell Biol., 16,( 1996 ), 5058 – 5068. | en_US |
dc.identifier.citedreference | G. Pallafacchina, E. Calabria, A.L. Serrano, J.M. Kalhovde, S. Schiaffino, A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proc. Natl. Acad. Sci. USA, 99,( 2002 ), 9213 – 9218. | en_US |
dc.identifier.citedreference | A.M. Fernandez, Functional inactivation of the IGF-1 and insulin receptors in skeletal muscle cause Type 2 diabetes. Genes Dev., 15,( 2001 ), 1926 – 1934. | en_US |
dc.identifier.citedreference | J.C. Bruning, M.D. Michael, J.N. Winnay, T. Hayashi, D. Horsch, D. Accili, L.J. Goodyear, C.R. Kahn, A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell, 2,( 1998 ), 559 – 569. | en_US |
dc.identifier.citedreference | S. Fletcher, K. Honeyman, A.M. Fall, P.L. Harding, R.D. Johnsen, S.D. Wilton, Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide. J. Gene Med., 8,( 2006 ), 207 – 216. | en_US |
dc.identifier.citedreference | J. Dong, D. Pan, Tsc2 is not a critical target of Akt during normal Drosophila development. Genes Dev., 18,( 2004 ), 2479 – 2484. | en_US |
dc.identifier.citedreference | X. Gao, D. Pan, TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth. Genes Dev., 15,( 2001 ), 1383 – 1392. | en_US |
dc.identifier.citedreference | N. Ito, G.M. Rubin, gigas, a Drosophila homolog of tuberous sclerosis gene product-2, regulates the cell cycle. Cell, 96,( 1999 ), 529 – 539. | en_US |
dc.identifier.citedreference | D.J. Glass, Molecular mechanisms modulating muscle mass. Trends Mol. Med., 9,( 2003 ), 344 – 350. | en_US |
dc.identifier.citedreference | T.N. Stitt, The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol. Cell, 14,( 2004 ), 395 – 403. | en_US |
dc.identifier.citedreference | M. Sandri, Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell, 117,( 2004 ), 399 – 412. | en_US |
dc.identifier.citedreference | C. Rommel, S.C. Bodine, B.A. Clarke, R. Rossman, L. Nunez, T.N. Stitt, G.D. Yancopoulos, D.J. Glass, Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat. Cell Biol., 3,( 2001 ), 1009 – 1013. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.